Orange Book product · Generic (ANDA)
HYDROCORTISONE
HYDROCORTISONE
At a glance
Approved Prior to Jan 1, 1982
Approved
Generic (ANDA)
Application
AT
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
HYDROCORTISONE
Strength
2.5%
Dosage form
CREAM
Route
TOPICAL
TE code
AT
Application
ANDA 085025
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of HYDROCORTISONE
- —CORT-DOMEBrand (NDA)
NDA 009585 · BAYER PHARMS
- 2018HYDROCORTISONEGeneric (ANDA)
ANDA 203810 · ENCUBE
- 2016ALA-CORTGeneric (ANDA)
ANDA 080706 · CROWN LABS
- 2010HYDROCORTISONEGeneric (ANDA)
ANDA 040879 · RISING
- 2004HYDROCORTISONEGeneric (ANDA)
ANDA 040503 · CHARTWELL MOLECULAR
- 1989HYDROCORTISONEGeneric (ANDA)
ANDA 089273 · TOPIDERM
- 1989HYDROCORTISONEGeneric (ANDA)
ANDA 089754 · ALPHARMA US PHARMS
- 1988NOGENIC HCGeneric (ANDA)
ANDA 087427 · IVAX PHARMS
- 1988HYDROCORTISONEGeneric (ANDA)
ANDA 089682 · ACTAVIS MID ATLANTIC
- 1988HYDROCORTISONEGeneric (ANDA)
ANDA 089706 · NASKA
- 1986HYDROCORTISONEGeneric (ANDA)
ANDA 089414 · FOUGERA PHARMS INC
- 1986HYDROCORTISONEGeneric (ANDA)
ANDA 089413 · PHARMADERM
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
